Mackenzie Financial Corp Novartis Ag Transaction History

Mackenzie Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $253,049 - $286,110	-3,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $256,620 - $282,780	3,000 New	3,000 $261,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $188,500 - $232,000	-2,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $188,299 - $215,375	2,500 New	2,500 $211,000
Q3 2018 Nov 15, 2018	SELL	$66.94 - $77.43 $2.03 Million - $2.35 Million	-30,392 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $1.56 Million - $1.87 Million	22,209 Added 271.4%	30,392 $2.46 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $139,596 - $149,845	1,930 Added 30.87%	8,183 $687,000
Q3 2017 Nov 13, 2017	SELL	$74.14 - $77.27 $815 - $849	-11 Reduced 0.18%	6,253 $537,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,264	6,264 $523,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.